Clinical development is becoming increasingly complex, with leaner teams, tighter timelines, evolving regulations and increasingly specialized therapies. In this Pharmatech feature, CEO of Caidya, Barbara Lopez Kunz explores how closer collaboration between sponsors and development partners can support better decision-making, from early development strategy and patient-centered trial design through to global execution and regulatory planning.
Back to Resource Center